ProductLife Group is a specialist in outsourced regulatory affairs and pharmacovigilance services for the healthcare, life sciences, and particularly the pharmaceutical sectors. Founded 25 years ago, the group operates in over 100 countries, primarily through global outsourcing contracts, serving a strong and diversified client base of more than 300 pharmaceutical companies, including 36 of the global top 50. Benefiting from double-digit growth and the expansion of its global outsourcing contracts, Productlife Group generated nearly €25 million in revenue in 2018 with solid profitability and is expected to double its size in the coming years.
Adviso Partners advised the shareholders of ProductLife Group on the majority sale of the company's capital to the investment fund 21 Invest France.